Rapid Dose Therapeutics Ships Production Line to Callan JMB for Planned Texas Manufacturing Collaboration

• Rapid Dose Therapeutics shipped a QuickStrip production line to Callan JMB for planned installation at its Texas cGMP facility.
• The collaboration targets U.S. production of fast-dissolving oral thin films, combining QuickStrip technology with Callan JMB's pharmaceutical logistics capabilities.
• The shipment advances a preliminary agreement announced November 13, 2025; manufacturing has not begun.
• Future production remains subject to definitive agreements, equipment qualification and regulatory requirements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Dose Therapeutics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610210916NEWSFILECNPR____20261021_320149_1) on October 21, 2026, and is solely responsible for the information contained therein.